Closed
SectorHealthcare
45.68 -1.55
24h
Min
43.75
Max
46.11
Income | 5.2M -66M |
---|---|
Sales | 15M 22M |
EPS | -0.82 |
Profit margin | -296.747 |
Employees | 208 |
EBITDA | 5.3M -63M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +34% upside |
Next Earnings | 7 Aug 2025 |
---|
Market Cap | 828M 3B |
---|---|
Previous open | 47.23 |
Previous close | 45.68 |
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 62.27 USD 34%
High 79 USD
Low 51 USD
Based on 17 Wall Street analysts offering 12 month price targets forKymera Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$